Daisuke Ide, Takahiro Fujino, Tsutomu Kobayashi, Aya Egashira, Akihiro Miyashita, Kentaro Mizuhara, Reiko Isa, Taku Tsukamoto, Shinsuke Mizutani, Hitoji Uchiyama, et al. Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio. International journal of hematology. 2024
Yui Niiyama-Uchibori, Haruya Okamoto, Akihiro Miyashita, Kentaro Mizuhara, Yuka Kanayama-Kawaji, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Satoshi Teramukai, et al. Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma. Hematological oncology. 2024. 42. 1. e3252
Akio Onishi, Yayoi Matsumura-Kimoto, Shinsuke Mizutani, Reiko Isa, Takahiro Fujino, Taku Tsukamoto, Akihiro Miyashita, Keita Okumura, Daichi Nishiyama, Koichi Hirakawa, et al. Negative impact of immunoparesis in response to anti-SARS-CoV-2 mRNA vaccination of patients with multiple myeloma. International journal of hematology. 2023
Yuka Kawaji-Kanayama, Taku Tsukamoto, Masakazu Nakano, Yuichi Tokuda, Hiroaki Nagata, Kentaro Mizuhara, Yoko Katsuragawa-Taminishi, Reiko Isa, Takahiro Fujino, Yayoi Matsumura-Kimoto, et al. miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma. Cancer science. 2023
Hayato Takeuchi, Tohru Inaba, Yukiko Shishido-Hara, Taku Tsukamoto, Shinsuke Mizutani, Takanari Okamoto, Seisuke Tanigawa, Takumi Yamanaka, Yoshinobu Takahashi, Eiichi Konishi, et al. Analysis of False-negative Findings of the Incomparable Accuracy and Swiftness of Flow Cytometric Diagnosis of Primary Central Nervous System Lymphoma. Neurologia medico-chirurgica. 2023. 63. 11. 495-502
水原 健太郎, 志村 勇司, 塚本 拓, 金井 昭教, 太田 沙絵子, 山口 順子, 村松 彩子, 岡本 明也, 民西 葉子, 金山 悠加, et al. 多発性骨髄腫でのM-MDSC誘導における腫瘍由来エキソソームを介したmiR-106a-5pとmiR-146a-5pの役割(The functional roles of miR-106a-5p and miR-146a-5p transferred by tumor-derived exosome in the induction of M-MDSCs in multiple myeloma). International Journal of Myeloma. 2023. 13. 3. 88-88
岡本 明也, 伊佐 怜子, 村松 彩子, 水原 健太郎, 民西 葉子[(桂川], 金山 悠加[川路], 藤野 貴大, 塚本 拓, 水谷 信介, 志村 勇司, et al. RSK/AKT/S6Kトリプル阻害剤TAS0612の抗骨髄腫効果(The anti-myeloma efficacy of TAS0612, a triple inhibitor for RSK, AKT, and S6K). International Journal of Myeloma. 2023. 13. 3. 89-89
伊佐 怜子, 堀中 真野, 塚本 拓, 水原 健太郎, 藤林 悠人, 民西 葉子, 岡本 明也, 安田 周祐, 金山 悠加, 木元 弥生, et al. 多発性骨髄腫に対するRSK2とAKTの二重標的戦略の理論基盤(The rationale for the dual-targeting therapeutic approach of RSK2 and AKT against multiple myeloma). International Journal of Myeloma. 2023. 13. 3. 116-116